Complex application of bacteriophages as a method of healthcare-associated infections control
© Brusina et al; licensee BioMed Central Ltd. 2015
Published: 16 June 2015
Prevention of healthcare-associated infections is one of the global problems in modern period of healthcare system development.
Prophylaxis of HAI in Russia.
Over the past 50 years in Russia, considerable progress in theoretical evidence and practical application of bacteriophages to treat and prevent healthcare-associated infections has accumulated. The efficient use of bacteriophages in epidemic outbreaks of healthcare-associated infections has been documented in numerous representative studies of different epidemiological centers in Russia: Kemerovo, St. Petersburg, Moscow, Nizhny Novgorod, Ufa and others.
One of the important areas of application is the use of bacteriophages for the decontamination of inanimate objects and surfaces in healthcare settings. Disinfection by using bacteriophages is the most suitable in epidemiologically relevant specialized departments such as intensive care units, burn units, etc. Drugs containing phages adapted to circulating bacterial strains will be more efficient compare to their non-adapted counterparts.
Numerous randomized controlled trials revealed different efficacy regarding the usage of bacteriophages in the environment. The greatest effect was obtained using Pseudomonas bacteriophage: complete elimination of the pathogen was achieved within 24 hours after a single application, and there were no new cases of healthcare-associated Pseudomonas infections. This is also the case for Salmonella bacteriophage effect (15-fold incidence reduction).
Disclosure of interest
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.